Why the study?
Does measurement of apolipoprotein B and apolipoprotein A-I improve the prediction of coronary heart disease mortality compared to routine clinical lipid measurements in US adults?
Population
7,594 US adults from the Third National Health and Nutrition Examination Survey mortality study
Comparison
Apolipoprotein B and apolipoprotein A-I… vs Traditional cardiovascular risk factors and…
Design
Cohort
Follow-up
median 124 person-months
Authors
Loading...
ApoB and apoB/apoA-I ratio may refine CHD mortality risk assessment; leaves open incremental value over routine lipids.
Does measurement of apolipoprotein B and apolipoprotein A-I improve the prediction of coronary heart disease mortality compared to routine clinical lipid measurements in US adults?
Apolipoprotein B and the apoB/apoA-I ratio are superior to routine clinical lipid measurements in predicting coronary heart disease mortality independently of traditional cardiovascular risk factors.
Sierra‐Johnson et al. (2008) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: